Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality

被引:0
|
作者
Bioletto, Fabio [1 ]
Pusterla, Alessia [1 ]
Fraire, Federica [1 ]
Sauro, Lorenzo [1 ]
Presti, Michela [2 ]
Arvat, Emanuela [2 ]
Ghigo, Ezio [1 ]
Procopio, Massimo [1 ]
Barale, Marco
机构
[1] Univ Turin, Dept Med Sci, Div Endocrinol Diabet & Metab, Corso Dogliotti 14, I-10126 Turin, Italy
[2] Univ Turin, Dept Med Sci, Div Oncol Endocrinol, I-10126 Turin, Italy
关键词
proton pump inhibitors; PPI; osteoporosis; bone density; bone quality; trabecular bone score; MINERAL DENSITY; HIP FRACTURE; RISK; OSTEOPOROSIS; THERAPY; MEDICATIONS; SCORE; EXPRESSION; MAGNESIUM; DISEASES;
D O I
10.1210/clinem/dgae598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Chronic use of proton pump inhibitors (PPIs) has been associated with an increase in bone fragility. However, evidence on the effect of chronic PPI use on bone density is conflicting, and data on bone microarchitectural quality are scarce. Objective: The primary aim of this study was to evaluate whether trabecular bone microarchitecture, assessed by trabecular bone score (TBS), is altered in chronic PPI users. The association between PPI use and bone density was also evaluated as a secondary endpoint. Methods: We extracted individual patient data from the 2005 to 2008 cycles of the population-based National Health and Nutrition Examination Survey (NHANES), in which lumbar spine dual-energy X-ray absorptiometry scans were acquired. TBS values were calculated from dual-energy X-ray absorptiometry images using a dedicated software. Multivariable linear regression analyses stratified by sex were performed to evaluate the association of chronic PPI use with TBS and bone mineral density (BMD), adjusting for relevant confounders. Results: A total of 7478 subjects were included (3961 men, 3517 women). After adjustment for relevant confounders, chronic PPI use was associated with a worse bone health profile in men, with lower TBS (-0.039; 95% CI, -0.058 to -0.020; P < .001), lumbar spine T-score (-0.27; 95% CI, -0.51 to -0.04; P = .023), total hip T-score (-0.21; 95% CI, -0.41 to -0.01; P = .041), and femoral neck T-score (-0.22; 95% CI, -0.44 to -0.00; P = .047). Notably, the association between chronic PPI use and degraded TBS remained statistically significant even after further adjustment for BMD at lumbar spine and femoral neck (-0.026; 95% CI, -0.039 to -0.012; P = .001). In contrast, no significant association was observed between chronic PPI use and either TBS or BMD in women. Conclusion: Chronic PPI use is associated with degraded trabecular bone quality in men, even after adjustment for BMD. No association was observed in women.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] ASSOCIATION OF URINE pH AND CHRONIC USE OF PROTON PUMP INHIBITOR
    Rambod, Mehdi
    Melikterminas, Edmond
    Atallah, Hani
    Saadi, Mohammed
    Connery, Sean
    Mulla, Zuber
    Tolouian, Ramin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 390 - 390
  • [2] Association of Proton Pump Inhibitor Use With Hyperparathyroidism
    Rubenstein, Joel H.
    McConnell, Daniel
    Beer, David G.
    Chak, Amitabh
    Metko, Val
    Clines, Gregory
    GASTROENTEROLOGY, 2016, 150 (04) : S835 - S835
  • [3] Proton pump inhibitor use and bone fractures in patients with chronic kidney disease
    Kommer, Andreas
    Kostev, Karel
    Schleicher, Eva Maria
    Weinmann-Menke, Julia
    Labenz, Christian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024,
  • [4] The "dangers'' of chronic proton pump inhibitor use
    Yadlapati, Rena
    Kahrilas, Peter J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (01) : 79 - 81
  • [5] THE ASSOCIATION BETWEEN HYPOMAGNESEMIA AND PROTON PUMP INHIBITOR USE IN CHRONIC KIDNEY DISEASE
    Van Laecke, Steven
    Nagler, Evi
    Van Biesen, Wim
    Jadoul, Michel
    Vanholder, Raymond
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 179 - 179
  • [6] The Association Between Prolonged Proton Pump Inhibitors Use and Bone Mineral Density
    Fattahi, Mohammad Reza
    Niknam, Ramin
    Shams, Mesbah
    Anushiravani, Amir
    Taghavi, Seyed Alireza
    Omrani, Gholamhossein Ranjbar
    Mahmoudi, Laleh
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2019, 12 : 349 - 355
  • [7] Sex-specific factors for bone density in patients with schizophrenia
    Lin, Chieh-Hsin
    Lin, Chun-Yuan
    Huang, Tiao-Lai
    Wang, Hong-Song
    Chang, Yue-Cune
    Lane, Hsien-Yuan
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (02) : 96 - 102
  • [8] Effects of Long-term Proton Pump Inhibitor Use on Bone Mineral Density
    Manickavasagan, Hanisha
    Schwartz, Jennifer
    Parikh, Meet
    Mannino, Christie
    Kirtane, Sachin
    Amori, Renee
    Ahmad, Asyia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S202 - S202
  • [9] Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease
    Klatte, Derk C. F.
    Gasparini, Alessandro
    Xu, Hong
    de Deco, Pietro
    Trevisan, Marco
    Johansson, Anna L. V.
    Wettermark, Bjorn
    Arnlov, Johan
    Janmaat, Cynthia J.
    Lindholm, Bengt
    Dekker, Friedo W.
    Coresh, Josef
    Grams, Morgan E.
    Carrero, Juan J.
    GASTROENTEROLOGY, 2017, 153 (03) : 702 - 710
  • [10] Bone mineral density variation in men is influenced by sex-specific and non sex-specific quantitative trait loci
    Peacock, Munro
    Koller, Daniel L.
    Lai, Dongbing
    Hui, Siu
    Foroud, Tatiana
    Econs, Michael J.
    BONE, 2009, 45 (03) : 443 - 448